Nanjing University of Traditional Chinese Medicine   Report issue

Academic/Hospital Phase 2
Founded: Nanjing China (1954)

Organization Overview

First Clinical Trial
2007
NCT00569088
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Amir Firouzjaei | Changzhou Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine | Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine | Nanjing Uinversity of Traditional Chinese Medicine | Nanjing University of Chinese Medicine | Nanjing University of Chinese Medicine, Xueping Zhou, Li Ren | Nanjing University of Traditional Chinese Medicine

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 11